Psychoeducation for Uveal Melanoma

N/AActive Not RecruitingNCT06075589

Jonsson Comprehensive Cancer Center108 enrolled

Overview

This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.

PRIMARY OBJECTIVE: I. To assess the efficacy of the psychoeducation intervention (compared to the control condition) in modifying illness perceptions of disease control, chronicity, and coherence (i.e., to become less threatening) over the course of the follow-up period. SECONDARY OBJECTIVE: I. To assess the efficacy of the psychoeducation intervention (compared to the control condition) in reducing the degree of participant's depressive and anxiety symptoms over the course of the follow-up period. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants watch two fifteen-minute educational videos and receive a mental health resource information sheet on study. ARM II: Patients receive enhanced treatment as usual and receive a mental health resource information sheet on study.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

108

Conditions

Uveal Melanoma

Interventions

Education for InterventionBEHAVIORAL

Participants watch two fifteen-minute educational videos and receive a mental health resource information sheet on study.

Best PracticeBEHAVIORAL

Patients receive enhanced treatment as usual and receive a mental health resource information sheet on study.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults (age 18 years and older at visit 1) * History of uveal melanoma as documented in their University of California, Los Angeles (UCLA) medical record * Receipt of uveal melanoma treatment and/or ongoing follow-up care at the UCLA Jules Stein Eye Institute, as documented in their UCLA medical record * Ability to read, write, and converse in English * Access to the internet via a computer or cell phone * Access to a personal email address * Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study Exclusion Criteria: \-

Locations (1)

University of California at Los Angeles

Los Angeles, California, United States

Outcomes

Primary Outcomes

Change in illness perceptions of disease control

Will be assessed using the Brief Illness Perception Questionnaire (BIPQ) and will be examined across treatment and control conditions using multilevel models.